Welcome to the international HTA database

Showing [16861 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Silver dressings for the treatment of patients with infected wounds: a review of clinical and cost-effectiveness
2010	National Institute for Health and Care Excellence (NICE)	Surgical correction of hallux valgus using minimal access techniques. NICE interventional procedures guidance 332
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Patient lifts and transfer equipment: a review of clinical and cost-effectiveness and guidelines
2010	National Institute for Health and Care Excellence (NICE)	Therapeutic endoscopic division of epidural adhesions. NICE interventional procedures guidance 333
2010	HAYES, Inc.	Psychosocial interventions as adjunct treatments for pediatric bipolar disorder
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Chair alarms in residential care and acute care: a review of the clinical effectiveness and safety
2010	HAYES, Inc.	Quantitative computed tomography for bone mineral density
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Deep brain stimulation for parkinson's disease and neurological movement disorders: a review of the clinical and cost-effectiveness and guidelines
2010	Institute of Health Economics (IHE)	Routine preoperative electrocardiogram and chest x-ray prior to elective surgery in Alberta, Canada
2010	Institute for Clinical and Economic Review (ICER)	Atrial fibrillation management options
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bupropion for adults with attention deficit hyperactivity disorder: a review of the clinical effectiveness and harms of misuse
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Cx501 for cutaneous lesions associated with recessive dystrophic epidermolysis bullosa
2010	Health Council of the Netherlands Gezondheidsraad (GR)	The 'thousand-dollar genome': an ethical exploration
2010	HAYES, Inc.	Rotating platform knee arthroplasty
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Treatment of periodontal disease in patients with diabetes: a review of clinical and cost-effectiveness
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Dabigatran etexilate (Pradaxa) for secondary prevention of venous thromboembolism (VTE)
2010	Health Services Assessment Collaboration (HSAC)	A systematic review of economic evaluations for tobacco control programs
2010	HAYES, Inc.	Routine ultrasound examination in low-risk pregnancy
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug therapy for prophylactic and post-exposure treatment of H1N1: a review of the comparative clinical and cost-effectiveness
2010	The Swedish Council on Health Technology Assessment (SBU)	[Silver-releasing dressings in treating chronic wounds]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Dienogest (Visabelle) for recurrent endometriosis - second or third line
2010	Health Services Assessment Collaboration (HSAC)	The effectiveness of non-pharmacological interventions for behavioural and psychological symptom management for people with dementia in residential care settings
2010	HAYES, Inc.	Screening, brief intervention, and referral to treatment (sbirt) for illicit drug use
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lindane and other treatments for lice and scabies: a review of clinical effectiveness and safety
2010	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Autologous fat transfer for cosmetic and reconstructive breast augmentation
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Duloxetine (Cymbalta) for chronic somatic pain
2010	HAYES, Inc.	Sirolimus-analog-eluting stents for treatment of coronary artery disease
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Positron emission tomography for epilepsy: clinical effectiveness and guidelines
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Ivabradine (Procoralan) for chronic heart failure
2010	HAYES, Inc.	Sirolimus-eluting stents for treatment of coronary artery disease
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bluetooth-enabled hearing technologies: a review of the clinical and cost-effectiveness
2010	NIHR Health Technology Assessment programme	Self monitoring of blood glucose in type 2 diabetes
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Linagliptin (Ondero) for type 2 diabetes mellitus - monotherapy or add-on therapy
2010	HAYES, Inc.	Total wrist arthroplasty
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Varenicline for smoking cessation in patients with psychiatric illness: a review of the risks
2010	Medical Advisory Secretariat (MAS)	Clinical utility of vitamin D testing: an evidence-based analysis
2010	Medical Advisory Secretariat (MAS)	Clinical utility of serologic testing for celiac disease in Ontario (symptomatic patients)
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Panitumumab (Vectibix) metastatic and/or recurrent head and neck cancer - first line
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pain scales in acute care settings: a review of the accuracy and reliability
2010	NIHR Health Technology Assessment programme	Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side-effects after major surgery: a systematic review
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Panobinostat (Faridak) for relapsed or refractory classical Hodgkin's lymphoma - third line
2010	Health Services Assessment Collaboration (HSAC)	Hypomethylating agents in the treatment of myelodysplastic syndromes: horizon scanning report
2010	HAYES, Inc.	Ventricular Assist Devices (VADs) in children and adolescents with chronic, end-stage heart failure
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prefabricated and custom made foot orthotics: a review of the clinical and cost-effectiveness
2010	NIHR Health Technology Assessment programme	Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment
2010	NIHR Health Technology Assessment programme	Development of the protocol for the proposed trial of beta interferon in multiple sclerosis
2010	NIHR Health Technology Assessment programme	Certolizumab pegol (CIMZIA) for the treatment of rheumatoid arthritis
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Infliximab for maintenance therapy for treatment of Crohn's disease: a review of the clinical effectiveness and guidelines
2010	NIHR Health Technology Assessment programme	Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence
2010	Finnish Office for Health Care Technology Assessment (Finohta)	Management of infection in patients in health centres. Final report of the MIKSTRA programme
2010	NIHR Health Technology Assessment programme	Capecitabine for the treatment of advanced gastric cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Percutaneous heart valves for valvular heart disease: an updated review of the clinical and cost-effectiveness and guidelines
2010	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
2010	NIHR Health Technology Assessment programme	Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Albumin versus synthetic plasma volume expanders: a review of the clinical and cost-effectiveness and guidelines for use
2010	NIHR Health Technology Assessment programme	The safety and effectiveness of different methods of ear wax removal: a systematic review and economic evaluation
2010	Health Services Assessment Collaboration (HSAC)	A comparison of gene expression profiling tests for breast cancer
2010	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve implantation: a critical appraisal of a health technology assessment and comparison with a rapid review
2010	NIHR Health Technology Assessment programme	A systematic review and economic evaluation of the clinical effectiveness and cost effectiveness of aldosterone antagonists for postmyocardial infarction heart failure
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Extracorporeal High-Intensity Focused Ultrasound (HIFU) in solid tumours]
2010	Agency for Healthcare Research and Quality (AHRQ)	Systematic reviews on selected pharmacogenetic tests for cancer treatment: CYP2D6 for Tamoxifen in breast cancer, KRAS for anti-EGFR antibodies in colorectal cancer, and BCR-ABL1 for tyrosine kinase inhibitors in chronic myeloid leukemia
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cognitive behavioural therapy for insomnia in adults: a review of the clinical effectiveness
2010	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Weighted blankets and vests: safety, efficacy and issues related to their use in different intervention settings]
2010	Agency for Healthcare Research and Quality (AHRQ)	A systematic review of loss-of-heterozygosity based topographic genotyping with PathfinderTG
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Remote ischemic conditioning: a review of the clinical effectiveness
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Priority-setting for elective surgery procedures with waiting lists of the public healthcare system of Catalonia
2010	Agency for Healthcare Research and Quality (AHRQ)	Report on the evidence regarding off-label indications for targeted therapies used in cancer treatment
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening programs for asymptomatic unruptured intracranial aneurysms: review of clinical effectiveness, cost-effectiveness, and evidence-based guidelines
2010	Agency for Healthcare Research and Quality (AHRQ)	Comparative evaluation of radiation treatments for clinically localized prostate cancer: an update
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Positive versus negative needleless connectors for central venous lines and peripheral lines: a review of the clinical effectiveness and guidelines
2010	HAYES, Inc.	Eovist (Bayer Schering Pharma AG) contrast agent for magnetic resonance imaging of the liver
2010	Agency for Healthcare Research and Quality (AHRQ)	Quality, regulation and clinical utility of laboratory-developed molecular tests
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of bupropion in patients with depression and the associated risk of seizures: safety
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Development of indicators to assess prevention programs for colorectal cancer in high risk populations]
2010	Agency for Healthcare Research and Quality (AHRQ)	Genetic tests for non-cancer diseases/conditions: a horizon scan
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fluconazole and pharmaceuticals without inactive ingredients for autism: a review of the clinical effectiveness
2010	Belgian Health Care Knowledge Centre (KCE)	Organisation and financing of chronic dialysis in Belgium
2010	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Is there a place for home oxygen therapy in the management of obstructive sleep apnea?]
2010	HAYES, Inc.	Nonmyeloablative (NMA) hematopoietic stem cell transplantation for renal cell carcinoma (RCC)
2010	Agency for Healthcare Research and Quality (AHRQ)	ECG-based signal analysis technologies
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Gabapentin tablets versus capsules: a review of the evidence regarding appropriate use
2010	HAYES, Inc.	Computed Tomography (CT)-guided lung biopsy with the superDimension i-Logica System (superDimension Inc.)
2010	Agency for Healthcare Research and Quality (AHRQ)	Diagnosis and treatment of secondary lymphedema
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Eden alternative and green house concept of care: review of clinical effectiveness, cost-effectiveness, and guidelines
2010	Agency for Healthcare Research and Quality (AHRQ)	Consideration of evidence on antiemetic drugs for nausea and vomiting associated with chemotherapy or radiation therapy in adults
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Afatinib for advanced and/or metastatic non-small cell lung cancer (NSCLC) with EGFR mutation - first line
2010	NIHR Health Technology Assessment programme	Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bifocal lenses under +0.50 diopter: a review of the clinical effectiveness and guidelines
2010	Agency for Healthcare Research and Quality (AHRQ)	Bone morphogenetic protein: the state of the evidence of on-label and off-label use
2010	NIHR Horizon Scanning Centre (NIHR HSC)	AIN-457 for posterior uveitis
2010	Medical Advisory Secretariat (MAS)	KRAS testing for anti-EGFR therapy in advanced colorectal cancer : an evidence-based and economic analysis
2010	NIHR Health Technology Assessment programme	Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pre-operative screening and post-operative monitoring in adult patients with obstructive sleep apnea: clinical effectiveness and guidelines
2010	Health Services Assessment Collaboration (HSAC)	The role of high-risk human papillomavirus testing for managing women with glandular abnormalities on cytology
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Apixaban for stroke prevention in atrial fibrillation
2010	Medical Advisory Secretariat (MAS)	Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer : an evidence-based and economic analysis
2010	NIHR Health Technology Assessment programme	Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sternal talon for cardiac surgery patients: a review of the clinical effectiveness and guidelines
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Axitinib for advanced and/or metastatic renal cell carcinoma - second line